180 related articles for article (PubMed ID: 31546618)
21. Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Feb; 96(1):e27-e37. PubMed ID: 28391660
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
[TBL] [Abstract][Full Text] [Related]
23. Galectin-1 studies in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
[TBL] [Abstract][Full Text] [Related]
25. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
Ozaki H; Hayashi H; Oshima K
Ophthalmic Res; 1996; 28(6):356-60. PubMed ID: 9032794
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
Sydorova M; Lee MS
Ophthalmic Res; 2005; 37(4):188-90. PubMed ID: 15990461
[TBL] [Abstract][Full Text] [Related]
27. Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Suzuki Y; Yao T; Okumura K; Seko Y; Kitano S
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1519-1525. PubMed ID: 31062144
[TBL] [Abstract][Full Text] [Related]
28. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
29. Lysyl oxidase-mediated elastin upregulation promotes the proliferation and migration of human retinal endothelial cells.
Zhang Y; Zhang Y; He S; Wang W
Adv Clin Exp Med; 2024 Jun; 33(6):641-651. PubMed ID: 38353503
[TBL] [Abstract][Full Text] [Related]
30. Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.
Balaiya S; Grant MB; Priluck J; Chalam KV
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E695-702. PubMed ID: 25159325
[TBL] [Abstract][Full Text] [Related]
31. Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy.
Mocan MC; Kadayifcilar S; Eldem B
Can J Ophthalmol; 2006 Dec; 41(6):747-52. PubMed ID: 17224958
[TBL] [Abstract][Full Text] [Related]
32. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
33. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
Dai Y; Wu Z; Wang F; Zhang Z; Yu M
Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
[TBL] [Abstract][Full Text] [Related]
34. Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy.
Mao C; Yan H
Indian J Ophthalmol; 2014 Jun; 62(6):699-701. PubMed ID: 25005199
[TBL] [Abstract][Full Text] [Related]
35. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.
Li J; Lu Q; Lu P
BMC Ophthalmol; 2018 Jun; 18(1):151. PubMed ID: 29940965
[TBL] [Abstract][Full Text] [Related]
36. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
37. INCREASED COMPLEMENT LEVELS IN HUMAN VITREOUS ASPIRATES OF PROLIFERATIVE DIABETIC RETINOPATHY AND RETINAL DETACHMENT EYES.
Manoharan N; Patnaik JL; Olson JL
Retina; 2019 Nov; 39(11):2212-2218. PubMed ID: 30148749
[TBL] [Abstract][Full Text] [Related]
38. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
[TBL] [Abstract][Full Text] [Related]
39. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.
Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M
Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575
[TBL] [Abstract][Full Text] [Related]
40. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
